GoldenGolden
Advanced Search
resTORbio

resTORbio

A biopharmaceutical company developing therapeutics for treating age-related diseases.

resTORbio is a biopharmaceutical company developing therapeutics for treating age-related diseases that is headquartered in Boston, Massachusetts and was founded in 2016 by Chen Schor and Joan Mannick.

Funding
Series A

On January 1, 2017 resTORbio completed their series A funding round with $25 million in funding from PureTech Health.

Series B

On November 30, 2017 resTORbio completed their series B funding rounds with $40 million in funding from OrbiMed (lead investor), Rock Springs Capital, Recharge Capital, Quan Capital, Nest.Bio Ventures, and Fidelity Management and Research Company.

Timeline

November 30, 2017
resTORbio raises a $40,000,000 series B round.
2016
resTORbio was founded by Chen Schor and Joan Mannick.

Funding rounds

People

Name
Role
LinkedIn

Chen Schor

Co-Founder, President and CEO

Joan Mannick

Co-Founder, Chief Medical Officer

Sarb Shergill

Vice President of Clinical Operations

Further reading

Title
Author
Link
Type
Date

resTORbio launches Phase Ib/IIa trial of RTB101 to treat Parkinson's

Drugdevelopment-technology

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.